108 related articles for article (PubMed ID: 23743538)
1. Primary non-Hodgkin lymphoma in the pterygopalatine fossa. A peculiar diagnosis with a minimally invasive endoscopic approach.
Seccia V; Pietrini M; Briganti T; Buda G
Ann Hematol; 2014 Feb; 93(2):345-6. PubMed ID: 23743538
[No Abstract] [Full Text] [Related]
2. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
Kato H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
[No Abstract] [Full Text] [Related]
3. Generalized granuloma annulare and non-Hodgkin's lymphoma.
Bassi A; Scarfi F; Galeone M; Arunachalam M; Difonzo E
Acta Derm Venereol; 2013 Jul; 93(4):484-5. PubMed ID: 23250047
[No Abstract] [Full Text] [Related]
4. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Czuczman MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
[No Abstract] [Full Text] [Related]
5. Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by metaregression.
Messori A; Fadda V; Maratea D; Trippoli S
Am J Hematol; 2013 May; 88(5):435. PubMed ID: 23420571
[No Abstract] [Full Text] [Related]
6. Lymphoma in the Waldeyer ring: a great masquerader.
Osborne RF; Hamilton JS; Avitia S
Ear Nose Throat J; 2009 Jun; 88(6):954-6. PubMed ID: 19517398
[No Abstract] [Full Text] [Related]
7. Primary mammary (non-Hodgkin) lymphoma presenting as locally advanced breast cancer.
Pruthi S; Stafyla VK; Phillips SW; Porrata LF; Reynolds CA
Mayo Clin Proc; 2004 Oct; 79(10):1310-4. PubMed ID: 15473415
[TBL] [Abstract][Full Text] [Related]
8. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
9. Diffuse large B-cell lymphoma with a bulky mass in the cranial vault.
Kanaya M; Endo T; Hashimoto D; Endo S; Takemura R; Okada K; Hatanaka KC; Matsuno Y; Teshima T
Int J Hematol; 2017 Aug; 106(2):147-148. PubMed ID: 28390034
[No Abstract] [Full Text] [Related]
10. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients.
Emir S; Vezir E; Azkur D; Demir HA; Metin A
Pediatr Hematol Oncol; 2013 Sep; 30(6):544-53. PubMed ID: 23647505
[TBL] [Abstract][Full Text] [Related]
12. A rare diagnosis of pancreatic tumour.
Chung CS; Liao WC; Wang HP
Gut; 2009 Feb; 58(2):188, 248. PubMed ID: 19136521
[No Abstract] [Full Text] [Related]
13. Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma.
Merli M; Maffioli M; Ferrario A; Passamonti F
Am J Hematol; 2013 Aug; 88(8):719-20. PubMed ID: 23686933
[No Abstract] [Full Text] [Related]
14. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
15. Indolent lymphoma: can rituximab resolve the watch-and-wait debate?
Ross E
J Natl Cancer Inst; 2010 Feb; 102(4):220-1. PubMed ID: 20145214
[No Abstract] [Full Text] [Related]
16. A case of primary renal lymphoma.
Hart S; Ellimoottil C; Shafer D; Mehta V; Turk TM
Urology; 2012 Oct; 80(4):763-5. PubMed ID: 22795375
[No Abstract] [Full Text] [Related]
17. Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
Gimeno E; Sánchez-González B; Alvarez-Larrán A; Pedro C; Abella E; Comín J; Saumell S; García-Pallarols F; Gómez M; Besses C; Salar A
Leuk Res; 2011 Mar; 35(3):358-62. PubMed ID: 20708263
[TBL] [Abstract][Full Text] [Related]
18. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
19. Treatment of localized lymphoma.
Tanvetyanon T
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
[No Abstract] [Full Text] [Related]
20. Lymphomatous polyposis as primary manifestation of mantle cell lymphoma.
Yu SC; Liu KL; Chang LC
Eur J Haematol; 2012 Aug; 89(2):185-6. PubMed ID: 22563740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
